News Daily News ACC/AHA Clarify How Social Determinants of Health Impact CVD Caitlin E. Cox August 28, 2024
News Daily News Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE Yael L. Maxwell August 19, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2024 Shelley Wood July 31, 2024
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Daily News FDA to Add New Diversity Requirements for Certain Clinical Studies Todd Neale July 15, 2024
News Daily News AHA Kicks Off Funding for Women’s Heart Health Amid Sex Gaps Caitlin E. Cox July 01, 2024
News Daily News ‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD Todd Neale June 27, 2024
News Daily News Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B Michael O'Riordan June 24, 2024
News Daily News ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal Yael L. Maxwell June 17, 2024
News Industry News CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction May 29, 2024
News Conference News EuroPCR 2024 POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival Yael L. Maxwell May 22, 2024
News Conference News EuroPCR 2024 Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO Caitlin E. Cox May 14, 2024
News Conference News ESC Heart Failure 2024 Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients Michael O'Riordan May 13, 2024
News Conference News SCAI 2024 AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE L.A. McKeown May 03, 2024
News Daily News EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts Todd Neale April 12, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024